The Fort Worth Press - MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure

Moderna, Inc., a U.S.-based biotechnology company known for its mRNA vaccine platform, has seen its shares rally sharply in recent trading. On August 19, 2026, Moderna and Merck announced that their investigational personalized mRNA cancer vaccine, used in combination with Keytruda, met the primary endpoint of a late-stage melanoma trial, with the combination regimen meeting the main study goal of significantly extending the time patients lived without their melanoma returning, compared with Keytruda alone. Moderna's stock price soared 177% that day, delivering a substantial blow to short sellers, marking one of its largest single-session gains on record and drawing renewed market attention to the company's expanding pipeline beyond vaccines.

The MRNAON/USDT trading pair went live on Spot at 09:00 on August 20, 2026 (UTC). Deposits are open, with withdrawals enabled from 09:00 on August 21, 2026 (UTC).

As the latest addition to MEXC's ongoing collaboration with Ondo, the listing reflects MEXC's efficiency in bringing trending assets to market, giving users timely investment exposure to one of the most closely watched biotech stocks in the current market. Ondo Stocks (formerly Ondo Global Markets) is a platform designed to bring traditional public securities on-chain through tokenized assets, enabling investors outside the United States to invest in publicly traded U.S. securities, including stocks and ETFs. These tokenized assets are freely transferable and usable in DeFi.

Tokenized stocks have taken on a growing role in MEXC's trading activity. In July, tokenized stocks became the largest category within MEXC's TradFi spot market, accounting for 62% of total spot trading volume. The trend underscores rising user demand for tokenized stocks, and MEXC will continue to expand its tokenized stock offering, empowering users to capture opportunities across global markets. In addition, MEXC 0808: Stock Season, the platform's annual brand event running through August 28 (UTC), is offering 0 Fees across Tokenized Stocks, Stock Futures and RealStocks, along with the opportunity to share in a $500,000 prize pool.

About MEXC

MEXC is the world's fastest-growing cryptocurrency exchange, trusted by more than 40 million users across 170+ markets. Built on a user-first philosophy, MEXC offers industry-leading 0-fee trading and access to over 3,000 digital assets. As the Gateway to Infinite Opportunities, MEXC provides a single platform where users can easily trade cryptocurrencies alongside tokenized assets, including stocks, ETFs, commodities, and precious metals.

MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC

For media inquiries, please contact MEXC PR team: [email protected]

Risk Disclaimer:

This content does not constitute investment advice. Given the volatility of financial markets, including digital assets, tokenized assets, and traditional financial products, investors should carefully assess market conditions, underlying asset fundamentals, and potential financial risks before making any investment or trading decisions.

Contact

Source article: https://chainwire.org/2026/08/21/mexc-lists-ondo-tokenized-stock-moderna-mrnaon-expanding-access-to-u-s-biotech-exposure/

A.Nunez--TFWP